Literature DB >> 24900573

Visible Light Controlled Release of Anticancer Drug through Double Activation of Prodrug.

Abugafar M L Hossion1, Moses Bio2, Gregory Nkepang2, Samuel G Awuah2, Youngjae You2.   

Abstract

We designed and synthesized a novel double activatable prodrug system (drug-linker-deactivated photosensitizer), containing a photocleavable aminoacrylate-linker and a deactivated photosensitizer, to achieve the spatiotemporally controlled release of parent drugs using visible light. Three prodrugs of CA-4, SN-38, and coumarin were prepared to demonstrate the activation of deactivated photosensitizer by cellular esterase and the release of parent drugs by visible light (540 nm) via photounclick chemistry. Among these prodrugs, nontoxic coumarin prodrug was used to quantify the release of parent drug in live cells. About 99% coumarin was released from the coumarin prodrug after 24 h of incubation with MCF-7 cells followed by irradiation with low intensity visible light (8 mW/cm(2)) for 30 min. Less toxic prodrugs of CA-4 and SN-38 killed cancer cells as effectively as free drugs after the double activation.

Entities:  

Keywords:  Prodrug; aminoacrylate; anticancer drug; photosensitizer; photounclick; visible/near IR

Year:  2012        PMID: 24900573      PMCID: PMC4027153          DOI: 10.1021/ml3003617

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  23 in total

Review 1.  Development and applications of photo-triggered theranostic agents.

Authors:  Prakash Rai; Srivalleesha Mallidi; Xiang Zheng; Ramtin Rahmanzadeh; Youssef Mir; Stefan Elrington; Ahmat Khurshid; Tayyaba Hasan
Journal:  Adv Drug Deliv Rev       Date:  2010-09-19       Impact factor: 15.470

2.  Lifetime and diffusion of singlet oxygen in a cell.

Authors:  Esben Skovsen; John W Snyder; John D C Lambert; Peter R Ogilby
Journal:  J Phys Chem B       Date:  2005-05-12       Impact factor: 2.991

Review 3.  Activatable photosensitizers for imaging and therapy.

Authors:  Jonathan F Lovell; Tracy W B Liu; Juan Chen; Gang Zheng
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

4.  Chromophore-assisted light inactivation of HaloTag fusion proteins labeled with eosin in living cells.

Authors:  Kiwamu Takemoto; Tomoki Matsuda; Mark McDougall; Dieter H Klaubert; Akira Hasegawa; Georgyi V Los; Keith V Wood; Atsushi Miyawaki; Takeharu Nagai
Journal:  ACS Chem Biol       Date:  2011-01-20       Impact factor: 5.100

5.  The optics of human skin.

Authors:  R R Anderson; J A Parrish
Journal:  J Invest Dermatol       Date:  1981-07       Impact factor: 8.551

6.  Photosensitizer drug delivery via an optical fiber.

Authors:  Matibur Zamadar; Goutam Ghosh; Adaickapillai Mahendran; Mihaela Minnis; Bonnie I Kruft; Ashwini Ghogare; David Aebisher; Alexander Greer
Journal:  J Am Chem Soc       Date:  2011-05-03       Impact factor: 15.419

7.  Probing the cysteine-34 position of endogenous serum albumin with thiol-binding doxorubicin derivatives. Improved efficacy of an acid-sensitive doxorubicin derivative with specific albumin-binding properties compared to that of the parent compound.

Authors:  Felix Kratz; André Warnecke; Karin Scheuermann; Cornelia Stockmar; Jürgen Schwab; Peter Lazar; Peter Drückes; Norbert Esser; Joachim Drevs; Didier Rognan; Caterina Bissantz; Caterina Hinderling; Gerd Folkers; Iduna Fichtner; Clemens Unger
Journal:  J Med Chem       Date:  2002-12-05       Impact factor: 7.446

Review 8.  Combretastatin A4 phosphate: a novel vascular disrupting agent.

Authors:  Govardhanan Nagaiah; Scot C Remick
Journal:  Future Oncol       Date:  2010-08       Impact factor: 3.404

Review 9.  Enzyme-catalyzed activation of anticancer prodrugs.

Authors:  Martijn Rooseboom; Jan N M Commandeur; Nico P E Vermeulen
Journal:  Pharmacol Rev       Date:  2004-03       Impact factor: 25.468

Review 10.  Irinotecan and its active metabolite, SN-38: review of bioanalytical methods and recent update from clinical pharmacology perspectives.

Authors:  Mullangi Ramesh; Preeti Ahlawat; Nuggehally R Srinivas
Journal:  Biomed Chromatogr       Date:  2010-01       Impact factor: 1.902

View more
  25 in total

Review 1.  Recent Advancements in Stimuli Responsive Drug Delivery Platforms for Active and Passive Cancer Targeting.

Authors:  Muhammad Abdur Rahim; Nasrullah Jan; Safiullah Khan; Hassan Shah; Asadullah Madni; Arshad Khan; Abdul Jabar; Shahzeb Khan; Abdelbary Elhissi; Zahid Hussain; Heather C Aziz; Muhammad Sohail; Mirazam Khan; Hnin Ei Thu
Journal:  Cancers (Basel)       Date:  2021-02-07       Impact factor: 6.639

2.  Anticancer drug released from near IR-activated prodrug overcomes spatiotemporal limits of singlet oxygen.

Authors:  Pallavi Rajaputra; Moses Bio; Gregory Nkepang; Pritam Thapa; Sukyung Woo; Youngjae You
Journal:  Bioorg Med Chem       Date:  2016-02-21       Impact factor: 3.641

3.  "Pointsource" delivery of a photosensitizer drug and singlet oxygen: eradication of glioma cells in vitro.

Authors:  Ashwini A Ghogare; Imran Rizvi; Tayyaba Hasan; Alexander Greer
Journal:  Photochem Photobiol       Date:  2014-04-21       Impact factor: 3.421

4.  Optically controlled release of DNA based on nonradiative relaxation process of quenchers.

Authors:  Yusuke Ogura; Atsushi Onishi; Takahiro Nishimura; Jun Tanida
Journal:  Biomed Opt Express       Date:  2016-05-09       Impact factor: 3.732

5.  Visible-to-NIR-Light Activated Release: From Small Molecules to Nanomaterials.

Authors:  Roy Weinstain; Tomáš Slanina; Dnyaneshwar Kand; Petr Klán
Journal:  Chem Rev       Date:  2020-10-30       Impact factor: 60.622

Review 6.  Prodrug strategies for targeted therapy triggered by reactive oxygen species.

Authors:  Jorge Peiró Cadahía; Viola Previtali; Nikolaj S Troelsen; Mads H Clausen
Journal:  Medchemcomm       Date:  2019-05-08       Impact factor: 3.597

Review 7.  Cyanine polyene reactivity: scope and biomedical applications.

Authors:  Alexander P Gorka; Roger R Nani; Martin J Schnermann
Journal:  Org Biomol Chem       Date:  2015-07-28       Impact factor: 3.876

Review 8.  Nanoplatforms for Targeted Stimuli-Responsive Drug Delivery: A Review of Platform Materials and Stimuli-Responsive Release and Targeting Mechanisms.

Authors:  Yuzhe Sun; Edward Davis
Journal:  Nanomaterials (Basel)       Date:  2021-03-16       Impact factor: 5.076

9.  Far-Red Light-Activatable Prodrug of Paclitaxel for the Combined Effects of Photodynamic Therapy and Site-Specific Paclitaxel Chemotherapy.

Authors:  Pritam Thapa; Mengjie Li; Moses Bio; Pallavi Rajaputra; Gregory Nkepang; Yajing Sun; Sukyung Woo; Youngjae You
Journal:  J Med Chem       Date:  2016-03-22       Impact factor: 7.446

10.  Fluorinated Photodynamic Therapy Device Tips and their Resistance to Fouling for In Vivo Sensitizer Release.

Authors:  Ashwini A Ghogare; Joann M Miller; Bikash Mondal; Alan M Lyons; Keith A Cengel; Theresa M Busch; Alexander Greer
Journal:  Photochem Photobiol       Date:  2015-11-04       Impact factor: 3.421

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.